Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 1996, for Humana Inc., a managed health care company offering HMO and PPO products to commercial groups, Medicare, and Medicaid-eligible individuals. The company operates through a network of providers and manages financial risk through utilization controls.
Key Financial Metrics
| Metric | Q1 1996 | Q1 1995 |
|---|---|---|
| Total Revenues | $1,588 million | $1,048 million |
| Premium Revenues | $1,560 million | $1,025 million |
| Net Income | $53 million | $53 million |
| Earnings Per Share | $0.32 | $0.32 |
| Operating Cash Flow | $162 million | $174 million |
| Cash and Equivalents (End of Period) | $279 million | $459 million |
| Long-Term Debt | $230 million | $250 million |
| Medical Loss Ratio | 81.7% | 80.6% |
| Administrative Cost Ratio | 14.7% | 13.7% |
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased 52.1% to $1.588 billion, driven primarily by the acquisition of EMPHESYS Financial Group, Inc. in Q4 1995, which contributed approximately $424 million in premium revenues.
- Membership Trends: Commercial membership decreased by 21,000 in Q1 1996 (vs. an increase of 136,300 in Q1 1995) due to the loss of a large customer group and pricing strategies. Conversely, Medicare risk membership increased by 11,900.
- Profitability Margins: While net income remained flat at $53 million, the medical loss ratio worsened to 81.7% from 80.6%, attributed to declining commercial premium rates and rising outpatient costs. The administrative cost ratio also increased to 14.7% due to EMPHESYS integration costs.
- Liquidity: Cash and cash equivalents decreased from $459 million in Q1 1995 to $279 million in Q1 1996, despite a $97 million increase during the quarter, due to higher starting balances in the prior year and investing activities.
Outlook, Risks, and Management Commentary
- Guidance: Management anticipates Commercial product membership gains of approximately 4% for calendar year 1996, while Medicare risk membership gains are expected to be 12% to 14%. Commercial premium rates are expected to decline 1% to 2% in 1996, while Medicare risk rates will increase approximately 8%.
- Cost Outlook: The medical loss ratio is not expected to improve for the remainder of 1996 due to competitive pricing and rising medical costs. Management is evaluating cost control initiatives in the Washington, D.C. market and recent expansion areas.
- New Contracts: Humana will begin providing services under a potential five-year, $3.8 billion contract with the Department of Defense (CHAMPUS) starting July 1, 1996. Management notes uncertainty regarding the success of this new program.
- Regulatory Risks: Legislative proposals regarding Medicare reimbursement rates pose a risk. Significant changes or loss of Medicare risk contracts could materially adversely affect the company.
- Capital Resources: Planned capital spending for 1996 is estimated at $65 million to $70 million. The company initiated a commercial paper program in April 1996 backed by a $600 million revolving credit agreement.
Investor Verification Checklist
- Verify the integration progress and cost impact of the EMPHESYS acquisition on future quarters.
- Monitor the medical loss ratio in the Washington, D.C. market and service area expansion markets for signs of improvement.
- Assess the impact of the new CHAMPUS contract on operational costs and revenue recognition starting July 1996.
- Track legislative developments regarding Medicare reimbursement rates and their potential effect on the 8% rate increase.
- Confirm the stability of commercial membership given the recent loss of a major customer group and anticipated rate reductions.